Amgen
Amgen
Amgen (pronounced: /ˈæm.dʒɛn/) is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. Founded in 1980, it is one of the world's largest independent biotechnology firms.
Etymology
The name "Amgen" is a portmanteau of the words "Applied Molecular Genetics", which was the company's name when it was founded.
History
Amgen was established in 1980 by George Rathmann, a former Abbott Laboratories executive. The company's initial focus was on molecular biology and biochemistry, with the goal of producing genetically engineered proteins for medical use.
Products
Amgen's product portfolio includes biopharmaceuticals in the areas of oncology, hematology, cardiovascular disease, inflammation, bone health, nephrology, and neuroscience. Some of its well-known products include Neulasta, Prolia, Enbrel, and Aranesp.
Research and Development
Amgen's research and development efforts are focused on leveraging its expertise in biotechnology to create innovative medicines for patients with serious illnesses. The company's R&D activities span a wide range of therapeutic areas, including oncology, cardiovascular disease, inflammation, bone health, and neuroscience.
Related Terms
- Biopharmaceutical
- Molecular biology
- Biochemistry
- Oncology
- Hematology
- Cardiovascular disease
- Inflammation
- Bone health
- Nephrology
- Neuroscience
External links
- Medical encyclopedia article on Amgen
- Wikipedia's article - Amgen
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski